Who
Juliet Thompson
Director
Company insider
Files Form 4 as: Director, Indivior Pharmaceuticals; Director, Gi Dynamics.
In numbers
- Trades disclosed
- 8
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 24 May 2018
- Last trade
- 13 May 2026
- Last filed
- 14 May 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 13 May 2026filed 14 May 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —6,518 at $0.00 | filing |
| 13 May 2026filed 14 May 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —6,518 at $0.00 | filing |
| 12 May 2026filed 14 May 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $43K1,117 at $38.28 | filing |
| 12 May 2026filed 14 May 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $43K1,117 at $38.28 | filing |
| 26 Jan 2026filed 28 Jan 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —3,722 at $0.00 | filing |
| 26 Jan 2026filed 28 Jan 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —3,722 at $0.00 | filing |
| 16 Dec 2019filed 18 Dec 2019 | Gi Dynamicsoption or derivative | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 24 May 2018filed 29 May 2018 | Gi Dynamicsoption or derivative | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.